SPSunil Dattatray Pawar

Sunil Dattatray Pawar

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sunil Dattatray Pawar has a total of 6 co-authors. Here are the top co-authors by number of shared publications:

  • Amol Deshpande

    Dr. Babasaheb Ambedkar Marathwada University Aurangabad, Department of Chemistry of S. B. E. S. Collage Aurangabad-431001, Maharashtra, India

    1 shared publication
  • Anil Shankarwar

    Dr. Babasaheb Ambedkar Marathwada University Aurangabad, Department of Chemistry of S. B. E. S. Collage Aurangabad-431001, Maharashtra, India

    1 shared publication
  • Deepak D. Kayande

    Dr. Babasaheb Ambedkar Marathwada University Aurangabad, Department of Chemistry of S. B. E. S. Collage Aurangabad-431001, Maharashtra, India

    1 shared publication
  • Kokila Pawar

    Dr. Babasaheb Ambedkar Marathwada University Aurangabad, Department of Chemistry of S. B. E. S. Collage Aurangabad-431001, Maharashtra, India

    1 shared publication
  • Mazahar Farooqui

    Department of Chemistry, Maulana Azad College, Aurangabad-431001, India

    1 shared publication
  • Sunil Dattatray Pawar

    Dr. Babasaheb Ambedkar Marathwada University Aurangabad, Department of Chemistry of S. B. E. S. Collage Aurangabad-431001, Maharashtra, India

    1 shared publication

Latest Publications

  • Open Access

    AN LC–ESI-MS/MS METHOD DEVELOPMENTAND ITS VALIDATIONFOR THE QUANTIFICATION OF PRALSETINIB IN K2EDTA HUMANPLASMA

    by Sunil Dattatray Pawar, Deepak D. Kayande, Kokila Pawar, Mazahar Farooqui, Anil Shankarwar, Amol Deshpande, Sunil Shankarwar

    Objective: Aim of the work is to developa simple LC-ESI-MS/MS approach for a sensitive, specific, and quantitative determination of pralsetinib in human K2EDTA plasma. Methods: The samples were separated using an isocratic mobile phase made up of 0.1%HCOOH, methanol and acetonitrile in 10:70:20(% v/v) fractions. In multiple reaction monitoring mode, mass transitions for pralsetinib were m/z 534.27/302.19 and for asciminib internal standard, they were 450.1/257.10 in positive ionization mode. Results: Linearity and a high r2 value (>0.99) characterize the calibration curve, which spans 141.5–5660 ng/ml. Theintra-batchaccuracywaswithin-8.44 to 5.69% relative errorandtheprecisionwaswithin3.14 to 4.92%. Theinter-batchaccuracywaswithin-5.26 to 4.63% relative error and the precision was within 3.32 to 4.93%. The extraction recoveries executed at three quality control levels and their mean recovery was 97.45%. Conclusion: In conclusion, a new approach to evaluating pralsetinib in human K2EDTA plasma has been approved for use in clinical, bioavailability, and bioequivalence investigations, and it may be used to quantify pralsetinib.